Literature DB >> 22940579

Clonal expansion and functional exhaustion of monoclonal marginal zone B cells in mixed cryoglobulinemia: the yin and yang of HCV-driven lymphoproliferation and autoimmunity.

Marcella Visentini1, Valentina Conti, Cristina Cristofoletti, Cristina Lazzeri, Ramona Marrapodi, Giandomenico Russo, Milvia Casato, Massimo Fiorilli.   

Abstract

Monoclonal marginal zone (MZ) B cells expressing a V(H)1-69-encoded idiotype accumulate in HCV-associated mixed cryoglobulinemia (MC). These cells recognize the E2 protein of HCV and their massive clonal expansion reflects the propensity of MZ B cells to proliferate robustly upon antigenic stimulation by microorganisms, a property that makes them prone to neoplastic transformation. V(H)1-69(+) B cells of MC patients are phenotypically heterogeneous and resemble either mature MZ B cells (IgM(+)CD27(+)CD21(high)) or the unusual CD21(low) B cells that accumulate in other immunological disorders such as common variable immunodeficiency (CVID) or HIV infection. The CD21(low) V(H)1-69(+) B cells of MC patients, like those of CVID and HIV patients, are anergic to BCR and TLR9 stimulation and display deregulation of several anergy-related genes; proliferative anergy is also observed in CD21(high) MZ-like V(H)1-69(+) B cells, that over-express the antiproliferative transcriptional repressor Stra13. Upon evolution to splenic marginal zone lymphoma, MZ-like V(H)1-69(+) B cells down-regulate Stra13 and partially recover their capacity to proliferate in response to TLR9 ligation. Like yin and yang, robust clonal expansion and early proliferative anergy may be viewed as the opposite forces balancing the responses of human MZ B cells to chronic microbial stimuli. Disruption of this balance facilitates autoimmunity and lymphoproliferation.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22940579     DOI: 10.1016/j.autrev.2012.08.016

Source DB:  PubMed          Journal:  Autoimmun Rev        ISSN: 1568-9972            Impact factor:   9.754


  9 in total

1.  Toll-like receptor stimulation in splenic marginal zone lymphoma can modulate cell signaling, activation and proliferation.

Authors:  Eleonora Fonte; Andreas Agathangelidis; Daniele Reverberi; Stavroula Ntoufa; Lydia Scarfò; Pamela Ranghetti; Giovanna Cutrona; Alessandra Tedeschi; Aliki Xochelli; Federico Caligaris-Cappio; Maurilio Ponzoni; Chrysoula Belessi; Zadie Davis; Miguel A Piris; David Oscier; Paolo Ghia; Kostas Stamatopoulos; Marta Muzio
Journal:  Haematologica       Date:  2015-08-20       Impact factor: 9.941

2.  Intravenous immunoglobulin replacement therapy in common variable immunodeficiency induces B cell depletion through differentiation into apoptosis-prone CD21(low) B cells.

Authors:  Milica Mitrevski; Ramona Marrapodi; Alessandro Camponeschi; Cristina Lazzeri; Laura Todi; Isabella Quinti; Massimo Fiorilli; Marcella Visentini
Journal:  Immunol Res       Date:  2014-12       Impact factor: 2.829

3.  Discovering the pathogenesis of autoimmune diseases at the 9th International Congress of Autoimmunity, Nice, France, 2014.

Authors:  Carlo Perricone; Guido Valesini
Journal:  Immunol Res       Date:  2014-12       Impact factor: 2.829

4.  Splenic marginal zone lymphomas in acquired C1-inhibitor deficiency: clinical and molecular characterization.

Authors:  Matteo Sbattella; Andrea Zanichelli; Paolo Ghia; Valter Gattei; Chiara Suffritti; Thomas Teatini; Marco Cicardi; Roberto Castelli
Journal:  Med Oncol       Date:  2018-08-02       Impact factor: 3.064

5.  Unique topics and issues in rheumatology and clinical immunology.

Authors:  Carlo Selmi
Journal:  Clin Rev Allergy Immunol       Date:  2014-08       Impact factor: 8.667

Review 6.  Innate and Adaptive Immune Responses in Chronic HCV Infection.

Authors:  Lynn B Dustin
Journal:  Curr Drug Targets       Date:  2017       Impact factor: 3.465

Review 7.  Immune control and failure in HCV infection--tipping the balance.

Authors:  Lynn B Dustin; Siobhán B Cashman; Stephen M Laidlaw
Journal:  J Leukoc Biol       Date:  2014-07-11       Impact factor: 4.962

Review 8.  ZEB Proteins in Leukemia: Friends, Foes, or Friendly Foes?

Authors:  Bieke Soen; Niels Vandamme; Geert Berx; Jürg Schwaller; Pieter Van Vlierberghe; Steven Goossens
Journal:  Hemasphere       Date:  2018-05-11

9.  Serum levels of immunoglobulin free light chains in patients with chronic hepatitis C presenting cryoglobulinemia.

Authors:  Isabela S Oliveira; Milena S Cabral; Larissa S Jesus; Raymundo Paraná; Ajax M Atta; Maria Luiza B Sousa Atta
Journal:  Braz J Infect Dis       Date:  2014-09-01       Impact factor: 3.257

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.